Zai Lab Limited (ZLAB)

NASDAQ: ZLAB · USD

$23.0

-0.55 (-2.3%)· Recorded snapshot

Market cap	2.6B
Revenue (ttm)	449.6M
Net income (ttm)	-188.2M
EPS (ttm)	-$0.17
Shares out	112.3M
Volume	624,536
Beta	0.72

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 449.6M
Net income (ttm): -188.2M
EPS (ttm): -$0.17
Market cap: 2.6B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-26.9

P25 n/aP50 n/aP75 n/a

ROIC-17.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ZLAB indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001704292
Company name	Zai Lab Limited
Country	China
Country code	US
CUSIP number	98887Q104
Earnings date	2026-11-05
Earnings time	bmo
Employees	1,784
Employees change	-85
Employees growth	-4.55%
Enterprise value	$2.2B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2013
Industry	Biotechnology
IPO date	2017-09-20
Is primary listing	No
Is SPAC	No
ISIN number	US98887Q1040
Last 10-K release date	2026-02-26
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$2.6B
Market cap category	Mid-Cap
Next earnings date	2026-11-05
Options	Yes
Price	$23.03
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ZLAB
Website	https://www.zailaboratory.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-0.74%
EV/Sales	4.88x
FCF / EV yield	-6.36%
FCF yield	-5.46%
Forward EV/Sales	4.75x
Forward P/S	5.53x
P/B ratio	4.36x
P/S ratio	5.69x
Price / tangible book value	4.93x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-58.74%
EBITDA margin	-55.2%
Gross margin	3.78%
Operating margin	-58.74%
Pretax margin	-42.42%
Profit margin	-41.86%
Profit per employee	$-105,501
Revenue per employee	$252,026
ROA	-14.75%
ROA (5Y)	-19.37%
ROCE	-40.87%
ROE	-26.91%
ROE (5Y)	-36.43%
ROIC	-17.9%
SBC / revenue	12.96%
Tax / revenue	-0.56%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	4
Gross profit growth	-54.52%
Net income growth years	4
Revenue growth	5.1%
Revenue growth (Q)	-3.33%
Revenue growth (QoQ)	6.73%
Revenue growth 3Y	21.32%
Revenue growth 5Y	38.96%
Revenue growth years	7

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-6.2M
Depreciation and amortization	$15.9M
EBIT	$-264.1M
EBITDA	$-248.2M
EPS	$-0.17
FCF per share	$-1.24
Financing cash flow	$44.6M
Free cash flow	$-139.6M
Free cash flow minus SBC	$-197.9M
Gross profit	$17M
Income taxes	$-2.5M
Investing cash flow	$-39.1M
Net borrowing	$53.4M
Net cash flow	$-124.7M
Net income	$-188.2M
Operating cash flow minus SBC	$-191.7M
Operating income	$-264.1M
Revenue	$449.6M
Stock-based compensation	$58.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	0.04
Book value per share	$5.41
Debt / equity	0.42
Interest coverage	-44.13
Long-term assets	$160.8M
Long-term liabilities	$39.2M
Net cash (debt)	$362.9M
Net cash / market cap	14.2%
Net cash growth	-32.88%
Net debt / equity	-0.6
Piotroski F-Score	2
Property, plant and equipment	$62.6M
Shareholders' equity	$607M
Tangible book value	$518.4M
Tangible book value per share	$4.62
Total assets	$1.1B
Total cash	$617.5M
Total debt	$254.6M
Total liabilities	$467.8M
WACC	7.65%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.4
Current assets	$914M
Current liabilities	$428.6M
Current ratio	2.13
Inventory turnover	5.67
Net working capital	$111.1M
Quick ratio	1.61
Working capital	$485.5M
Working capital turnover	0.76

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-6.01%
Dividend yield	0%
Shareholder yield	-6.01%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$21.73
1D price change	-2.33%
1M price change	-8.77%
1M total return	-8.77%
1W price change	-9.13%
1W total return	-9.13%
1Y price change	-13.48%
1Y return CAGR	-13.49%
1Y total return	-13.48%
20-day SMA	$24.16
200-day SMA	$20.95
3M price change	22.26%
3M total return	22.26%
3Y price change	-3.02%
3Y return CAGR	-1.02%
3Y total return	-3.02%
50-day SMA	$25.10
50-day SMA vs 200-day SMA	50over200
52-week high	$27.50
52-week high date	2026-09-02
52-week low	$15.96
52-week low date	2026-02-02
5Y price change	-78.28%
5Y return CAGR	-26.32%
5Y total return	-78.28%
6M price change	4.16%
6M total return	4.16%
All-time high	$193.54
All-time high date	2021-01-20
All-time low	$13.48
All-time low date	2024-04-18
Average true range (ATR)	$1.40
Average volume	1M
Beta (1Y)	2.17
Beta (2Y)	1.19
Beta (5Y)	0.72
Change from 52-week high	-16.25%
Change from 52-week low	44.3%
Change from all-time high	-88.22%
Change from all-time low	69.07%
Change from open	-0.86%
Day's gap	-1.48%
Dollar volume	$14.4M
High price	$23.44
Low price	$22.69
Monthly RSI	47
Open price	$23.23
Position in 52-week range	45.33%
Premarket change	-1.4%
Premarket close	$23.58
Premarket price	$23.25
Premarket volume	2.4K
Previous close	$23.58
Price vs 150-day SMA	4.89%
Price vs 20-day SMA	-5.66%
Price vs 200-day SMA	8.8%
Price vs 50-day SMA	-9.2%
Relative volume	0.6
RSI	43.2
Sharpe ratio	-0.11
Sharpe ratio (3Y)	0.2
Sharpe ratio (5Y)	-0.08
Sortino ratio	-0.05
Sortino ratio (3Y)	0.41
Sortino ratio (5Y)	-0.04
Volume	624.5K
Weekly RSI	49.89
YTD price change	29.2%
YTD total return	29.2%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97.1M
Float percentage	86.5%
Shares change (QoQ)	0.87%
Shares change (YoY)	6.01%
Shares held by insiders	2.18%
Shares held by institutions	67.75%
Shares outstanding	112.3M
Short % of shares	6.5%
Short ratio	8.4 days

Deeper analysis on ZLAB

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ZLAB report

Is a complete ZLAB research report available?

No complete published report is available for Zai Lab Limited (ZLAB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Zai Lab Limited (ZLAB)

Price

Financial snapshot

Fair-value bridge

Latest news · ZLAB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ZLAB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on ZLAB

Frequently asked questions